EHC FY 2009 Earnings Report — Encompass Health Corporation Revenue & Financial Results | Market Cap Arena

Encompass Health CorporationEHC

FY 2009 Earnings

Reported February 23, 2010

Quarter Comparison

Revenue

Operating Income

Gross Margin

Net Margin

EPS (Diluted)

Free Cash Flow

Metric	FY 2009	Prior Q	FY 2008	QoQ Change	YoY Change
Revenue	$1.9B	—	$1.8B	—	4.5%
Op. Income	$277M	—	$407M	—	-31.9%
Gross Margin	100.0%	—	97.3%	—	2.7pp
Net Margin	5.0%	—	13.8%	—	-8.8pp
EPS (Diluted)	$0.77	—	$2.62	—	-70.6%
Free Cash Flow	$334M	—	$153M	—	118.0%

Revenue Flow

Item	Amount
REVENUE	$1.9B
Cost of Revenue	$0
GROSS PROFIT	$1.9B
R&D Expenses	$0
Selling & Marketing	$0
General & Administrative	$1.3B
SG&A Expenses	$1.3B
Other Expenses	$652M
Operating Expenses	$1.9B
Cost & Expenses	$1.9B
OPERATING INCOME	$277M
Interest Income	$0
Interest Expense	$126M
Other Income/Expenses	-$153M
INCOME BEFORE TAX	$124M
Income Tax Expense	-$3M
Net Income from Continuing Ops	$127M
Net Income from Discontinued Ops	$2M
Other Adjustments	$0
NET INCOME	$95M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$69M
D&A	$71M
EBIT	$249M
EBITDA	$320M
EPS	$1
EPS Diluted	$1

Income Statement

Item	Amount
REVENUE	$1.9B
Cost of Revenue	$0
GROSS PROFIT	$1.9B
R&D Expenses	$0
Selling & Marketing	$0
General & Administrative	$1.3B
SG&A Expenses	$1.3B
Other Expenses	$652M
Operating Expenses	$1.9B
Cost & Expenses	$1.9B
OPERATING INCOME	$277M
Interest Income	$0
Interest Expense	$126M
Other Income/Expenses	-$153M
INCOME BEFORE TAX	$124M
Income Tax Expense	-$3M
Net Income from Continuing Ops	$127M
Net Income from Discontinued Ops	$2M
Other Adjustments	$0
NET INCOME	$95M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$69M
D&A	$71M
EBIT	$249M
EBITDA	$320M
EPS	$1
EPS Diluted	$1

Cash Flow Statement

Item	Amount
Net Income	$127M
Depreciation & Amortization	$71M
Stock-Based Compensation	$13M
Deferred Income Tax	$4M
Other Non-Cash Items	$203M
Change in Working Capital	-$12M
OPERATING CASH FLOW	$406M
Capital Expenditure	-$73M
Acquisitions (Net)	$3M
Purchases of Investments	-$10M
Sales/Maturities of Investments	$6M
Other Investing Activities	-$59M
NET CASH FROM INVESTING	-$133M
Net Debt Issuance	-$168M
Common Stock Repurchased	$0
Common Dividends Paid	-$33M
Other Financing Activities	$2M
NET CASH FROM FINANCING	-$224M
FREE CASH FLOW	$334M
Net Change in Cash	$49M

Balance Sheet

Item	Amount
Cash & Equivalents	$81M
Short-Term Investments	$3M
Net Receivables	$220M
Inventory	$0
Other Current Assets	$68M
TOTAL CURRENT ASSETS	$426M
PP&E (Net)	$665M
Goodwill	$416M
Intangible Assets	$37M
Long-Term Investments	$29M
Tax Assets	$10M
Other Non-Current Assets	$98M
TOTAL NON-CURRENT ASSETS	$1.3B
TOTAL ASSETS	$1.7B
Account Payables	$50M
Short-Term Debt	$22M
Deferred Revenue	$131M
Other Current Liabilities	$242M
TOTAL CURRENT LIABILITIES	$391M
Long-Term Debt	$1.6B
Deferred Revenue NC	$0
Deferred Tax Liabilities	$0
Other Non-Current Liabilities	$547M
TOTAL NON-CURRENT LIABILITIES	$2.2B
TOTAL LIABILITIES	$2.6B
Common Stock	$1M
Additional Paid-In Capital	$2.9B
Retained Earnings	-$3.7B
Treasury Stock	-$138M
Accum. Other Comp. Income	-$387M
Other Equity	$387M
TOTAL STOCKHOLDERS' EQUITY	-$974M
Minority Interest	$76M
TOTAL EQUITY	-$898M
TOTAL LIABILITIES & EQUITY	$1.7B
Total Debt	$1.7B
Net Debt	$1.6B